Wells Fargo’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $534K | Buy |
47,566
+1,202
| +3% | +$13.5K | ﹤0.01% | 3739 |
|
|
2025
Q1 | $212K | Buy |
46,364
+942
| +2% | +$4.31K | ﹤0.01% | 4225 |
|
|
2024
Q4 | $256K | Buy |
45,422
+9,083
| +25% | +$51.2K | ﹤0.01% | 4164 |
|
|
2024
Q3 | $176K | Buy |
36,339
+1,400
| +4% | +$6.78K | ﹤0.01% | 4281 |
|
|
2024
Q2 | $171K | Buy |
34,939
+7,956
| +29% | +$38.8K | ﹤0.01% | 4267 |
|
|
2024
Q1 | $358K | Buy |
26,983
+10,381
| +63% | +$138K | ﹤0.01% | 3755 |
|
|
2023
Q4 | $231K | Sell |
16,602
-47,183
| -74% | -$658K | ﹤0.01% | 4001 |
|
|
2023
Q3 | $846K | Buy |
63,785
+3,314
| +5% | +$43.9K | ﹤0.01% | 3187 |
|
|
2023
Q2 | $1.13M | Buy |
60,471
+7,856
| +15% | +$147K | ﹤0.01% | 3199 |
|
|
2023
Q1 | $759K | Buy |
52,615
+50,055
| +1,955% | +$722K | ﹤0.01% | 3349 |
|
|
2022
Q4 | $49.5K | Sell |
2,560
-4,027
| -61% | -$77.9K | ﹤0.01% | 4557 |
|
|
2022
Q3 | $227K | Buy |
6,587
+6,006
| +1,034% | +$207K | ﹤0.01% | 3906 |
|
|
2022
Q2 | $9K | Sell |
581
-3,566
| -86% | -$55.2K | ﹤0.01% | 5514 |
|
|
2022
Q1 | $94K | Sell |
4,147
-456
| -10% | -$10.3K | ﹤0.01% | 5045 |
|
|
2021
Q4 | $170K | Buy |
4,603
+4,524
| +5,727% | +$167K | ﹤0.01% | 4981 |
|
|
2021
Q3 | $4K | Sell |
79
-21
| -21% | -$1.06K | ﹤0.01% | 6127 |
|
|
2021
Q2 | $6K | Buy |
+100
| New | +$6K | ﹤0.01% | 5961 |
|